Ferroptosis has been implicated in a number of disorders such as neurodegenerative diseases (amyotrophic lateral sclerosis (ALS), Alzheimers disease (AD), Parkinsons disease (PD), and Huntingtons disease (HD), etc.), ischemia/reperfusion injury, and kidney degeneration
It is likely that the larger number of statistically significant changes to the microbiome observed in the groups switched from WD to LD reflects their more numerous exposures to different diets, longitudinal changes in dietary exposure, the stress associated with diet switch, the negative energy state achieved by treatment and/or diet-driven weight loss, or a combination of these factors, but it may also be related to differences in terminal body weight and fat mass since both adiposity and diet composition have been shown to modulate the mouse gut microbiome profile
This mode of action confirms what the experts have been saying for several years, namely that it is a reduction in calorie intake that remains the main means of losing weight (physical exercise has enormous health benefits, but does not have major effects on weight loss)
Many patients begin noticing changes in appetite and waist circumference within the first several weeks, while visible abdominal fat reduction typically becomes more apparent over a few months of consistent treatment
(8) N S Linkova, B I Kuznik, and V Kh Khavinson (2012) (Peptide Ala-Glu-Asp-Gly and interferon gamma: their role in immune response during aging) Advances in Gerontology, 2012, Volume 25 (Issue 3), Pages 478-82
& Madan, A
